Peptide Comparison
EpithalonvsCartalax
A tiny but mighty four-amino-acid peptide that activates your body's telomerase enzyme—essentially helping your cells hit the 'reset' button on aging by protecting and lengthening the protective caps on your chromosomes.
Chondroprotective tripeptide bioregulator (Ala-Glu-Asp) that activates chondrogenic differentiation through SOX9/COL2A1/aggrecan upregulation, reverses senescence-associated secretory phenotype in aging chondrocytes, and provides geroprotective effects through SIRT-6 upregulation and p16/p21/p53 suppression
At a Glance
Quick
comparison
Dose Range
Epithalon
5–10 mg
Cartalax
2–5 mg
Frequency
Epithalon
Once daily
Cartalax
Once daily
Administration
Epithalon
Subcutaneous injection
Cartalax
Oral (capsule)
Cycle Length
Epithalon
4-6 weeks
Cartalax
12+ weeks
Onset Speed
Epithalon
Gradual (3-4 weeks)
Cartalax
Gradual (3-4 weeks)
Evidence Level
Epithalon
Limited human trials
Cartalax
Moderate human trials (Phase 1-2)
Efficacy
Benefit
ratings
Telomere Protection
Sleep Quality
Cellular Longevity
Anti-Aging
Healing & Recovery
Hormone Support
Technical Data
Compound
specifications
Epithalon
Molecular Formula
C14H22N4O9
Molecular Weight
390.35 g/mol
Half-Life
2-4 hours (estimated)
Bioavailability
High when injected subcutaneously
CAS Number
307297-39-8
Cartalax
Molecular Formula
C12H19N3O8
Molecular Weight
333.3 g/mol
Half-Life
Short plasma half-life typical of tripeptides (minutes to hours); biological effects persist for weeks to months through epigenetic gene regulation; metabolized to constituent amino acids
Bioavailability
Orally bioavailable via intestinal peptide transporters (PepT1/PepT2, LAT1); 10-fold more potent than crude cartilage polypeptide complex at chondrogenic activation (200 vs 2000 ng/mL effective concentration)
CAS Number
Not yet registered (research compound)
Protocols
Dosing
tiers
Epithalon
Cartalax
Applications
Best
suited for
Epithalon
Longevity Enthusiasts
If you're serious about healthy aging and want to support your cells at the deepest level, Epithalon targets one of the fundamental mechanisms of cellular aging—telomere shortening. It's like giving your cells' protective caps a little extra reinforcement.
Sleep Quality Seekers
Epithalon helps regulate melatonin production by supporting your pineal gland. Many users report better sleep quality and more consistent sleep-wake cycles, especially those who've noticed their sleep getting worse with age.
Those Concerned About Oxidative Stress
Beyond its telomere effects, Epithalon acts as an antioxidant. If you're exposed to environmental stressors, have a demanding lifestyle, or simply want extra cellular protection, this peptide offers multiple mechanisms of support.
Immune System Support (Age-Related)
As we age, our immune system naturally weakens—a process called immunosenescence. Research suggests Epithalon may help maintain immune function by supporting the thymus and immune cell health, potentially keeping your defenses stronger as you age.
Cartalax
Cartilage regeneration and protection in age-related osteoarthritis
Cartalax is particularly well-suited for individuals focused on cartilage regeneration and protection in age-related osteoarthritis. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Connective tissue repair and maintenance in aging individuals
Cartalax is particularly well-suited for individuals focused on connective tissue repair and maintenance in aging individuals. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Geroprotective therapy targeting the SIRT-6/senescence axis in musculoskeletal tissue
Cartalax is particularly well-suited for individuals focused on geroprotective therapy targeting the sirt-6/senescence axis in musculoskeletal tissue. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Complementing conventional osteoarthritis treatments with bioregulatory peptide therapy
Cartalax is particularly well-suited for individuals focused on complementing conventional osteoarthritis treatments with bioregulatory peptide therapy. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety Profile
Side
effects
Epithalon
Common
- Injection site redness
- Mild headache
- Temporary fatigue
Uncommon
- Vivid dreams
- Sleep pattern changes
Serious
- Allergic reaction
Cartalax
Common
- Mild injection site reaction
- Mild GI discomfort
- Mild fatigue
- Transient joint stiffness
Uncommon
- Temporary increase in joint discomfort
Serious
- No documented serious adverse effects
Research Status
Safety
& evidence
Epithalon
Evidence Level
Limited human trials
FDA Status
Research compound
Safety Overview
Epithalon has shown a favorable safety profile across decades of research, primarily conducted in Russia. Studies spanning up to 15 years of follow-up have reported no severe adverse events in older adults using Epithalon or its natural precursor Epithalamin. The peptide appears well-tolerated with minimal side effects, mostly limited to mild injection site reactions. However, large-scale clinical trials outside of Russia are still needed.
Contraindications
- xPregnancy or planning to become pregnant
- xCurrently breastfeeding
- xActive cancer or history of cancer
- xKnown allergy to peptide components
- xChildren and adolescents
Cartalax
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Cartalax (polypeptide complex from bovine cartilage) has not undergone formal FDA approval or rigorous clinical safety trials. The safety profile is based on traditional use in Russia and Eastern Europe as a cartilage extract supplement, with limited published safety data. As a complex mixture of polypeptides, collagens, and proteoglycans, the actual active components and their pharmacology are undefined, making toxicity prediction impossible. Potential allergic reactions to bovine proteins exist, and contamination risks from source animal tissues cannot be ruled out without pharmaceutical manufacturing standards.
Contraindications
- xKnown hypersensitivity to peptide bioregulators or constituent amino acids (alanine, glutamic acid, aspartic acid)
- xPregnancy and breastfeeding — insufficient reproductive safety data
- xActive joint infection — treat infection before initiating peptide bioregulator therapy
- xMalignant bone or cartilage tumors — proliferative effects of peptide bioregulators may be contraindicated
Decision Guide
Which is
right for you?
Choose Epithalon if...
- Longevity and healthy aging
- Cellular rejuvenation
- Sleep quality improvement
- Antioxidant support
Choose Cartalax if...
- Cartilage regeneration and protection in age-related osteoarthritis
- Connective tissue repair and maintenance in aging individuals
- Geroprotective therapy targeting the SIRT-6/senescence axis in musculoskeletal tissue
- Complementing conventional osteoarthritis treatments with bioregulatory peptide therapy